Clinical Trial Update: TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (TOTEM) is evaluating testosterone treatment for neuroprotection and myelin repair in relapsing-remitting multiple sclerosis, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Status: RECRUITING